Type 2 diabetes in the young: Why we should worry by Thanabalasingham, G, Owen, K

Diagnosis and management of maturity onset diabetes of the young (MODY). by Thanabalasingham, G, Owen, K

Acromegaly: Beyond surgery. by Thanabalasingham, G, Grossman, AB

Diagnosis and management of maturity onset diabetes of the young (MODY). by Thanabalasingham, G, Owen, K

Diagnosis and management of maturity onset diabetes of the young (MODY) by Thanabalasingham, G, Owen, K

Treatment of pituitary tumors: history. by Thanabalasingham, G, Karavitaki, N, Cudlip, S, Wass, J

Diabetes in pregnancy: time to focus on women with type 2 diabetes by Hirst, JE, Frise, C, Thanabalasingham, G, Owen, K

Differences in thrombotic and inflammatory markers comparing subjects with maturity onset diabetes of the young and type 2 diabetes by Bottomley, M, Thanabalasingham, G, Hess, K, Owen, K, Ajjan, R

Diagnostic and therapeutic challenge in a patient with mixed phenotype diabetes by Juszczak, A, Thanabalasingham, G, Khonsari, M, Webster, A, Owen, K

Maturity onset diabetes of the young is characterised by less thrombotic fibrin network structure compared with phenotypically similar type 2 diabetes subjects by Ajjan, R, Bottomley, M, Thanabalasingham, G, Alzahrani, S, Hess, K, Owen, K

Extending criteria for genetic testing increases diagnosis of maturity-onset diabetes of the young by Thanabalasingham, G, Pal, A, Farmer, A, Ellard, S, McCarthy, M, Owen, K

Maturity onset diabetes of the young and fibrin-related thrombosis risk by Sagar, RC, Phoenix, F, Thanabalasingham, G, Naseem, K, Ajjan, RA, Owen, KR

One is never enough: a case report of three different diabetes phenotypes in a single family by Kavvoura, F, Thanabalasingham, G, Webster, A, Mann, N, Ellard, S, Gloyn, A, Owen, K

Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations. by Owen, K, Thanabalasingham, G, James, T, Karpe, F, Farmer, A, McCarthy, M, Gloyn, A

Refractory hypercalcaemia secondary to parathyroid carcinoma: response to high-dose denosumab. by Karuppiah, D, Thanabalasingham, G, Shine, B, Wang, L, Sadler, G, Karavitaki, N, Grossman, AB

Nonsurgical cerebrospinal fluid rhinorrhea in invasive macroprolactinoma: incidence, radiological, and clinicopathological features. by Suliman, S, Gurlek, A, Byrne, J, Sullivan, N, Thanabalasingham, G, Cudlip, S, Ansorge, O, Wass, J

Assessment of the pathogenicity of the previously reported D526N Hepatocyte Nuclear factor-1 alpha (HNF1A) variant using a combined genetic, in silico and functional approach by Hassanali, N, Rundle, J, Thanabalasingham, G, Owen, K, Wilson, J, McCarthy, M, Gloyn, A

Effects of the COVID-19 pandemic on management and outcomes of gestational diabetes by Hirst, J, Patell, M, Owen, K, Thanabalasingham, G, Houlden, R, Lozano, A, Gibson, S, Frise, C

Atypical phenotype associated with reported GCK exon 10 deletions: Clinical judgement is needed alongside appropriate genetic investigations. by Thanabalasingham, G, Kaur, K, Talbot, F, Colclough, K, Mathews, A, Taylor, J, Ellard, S, Owen, K

Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenom... by Karavitaki, N, Thanabalasingham, G, Shore, H, Trifanescu, R, Ansorge, O, Meston, N, Turner, H, Wass, J